Nature Communications (Feb 2019)

Genomic characterization of genes encoding histone acetylation modulator proteins identifies therapeutic targets for cancer treatment

  • Zhongyi Hu,
  • Junzhi Zhou,
  • Junjie Jiang,
  • Jiao Yuan,
  • Youyou Zhang,
  • Xuepeng Wei,
  • Nicki Loo,
  • Yueying Wang,
  • Yutian Pan,
  • Tianli Zhang,
  • Xiaomin Zhong,
  • Meixiao Long,
  • Kathleen T. Montone,
  • Janos L. Tanyi,
  • Yi Fan,
  • Tian-Li Wang,
  • Ie-Ming Shih,
  • Xiaowen Hu,
  • Lin Zhang

DOI
https://doi.org/10.1038/s41467-019-08554-x
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 17

Abstract

Read online

Targeting histone acetylation modulators (HAMPs) is a promising avenue of drug discovery in cancer research. Here, the authors integrate multi-dimensional genomic profiles to systematically investigate recurrent genomic alterations in HAMPs, identifying potential therapeutic targets for precision epigenetic treatment.